LGND
Ligand Pharmaceuticals Inc
Price:  
124.98 
USD
Volume:  
183,378.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

LGND Intrinsic Value

-241.90 %
Upside

What is the intrinsic value of LGND?

As of 2025-07-11, the Intrinsic Value of Ligand Pharmaceuticals Inc (LGND) is (177.35) USD. This LGND valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 124.98 USD, the upside of Ligand Pharmaceuticals Inc is -241.90%.

The range of the Intrinsic Value is (462.04) - (111.76) USD

Is LGND undervalued or overvalued?

Based on its market price of 124.98 USD and our intrinsic valuation, Ligand Pharmaceuticals Inc (LGND) is overvalued by 241.90%.

Note: result may not be accurate due to the invalid valuation result of DCF model.

124.98 USD
Stock Price
(177.35) USD
Intrinsic Value
Intrinsic Value Details

LGND Intrinsic Value - Valuation Summary

Range Selected Upside
a
DCF (Growth 5y) (462.04) - (111.76) (177.35) -241.9%
DCF (Growth 10y) (161.67) - (646.10) (252.82) -302.3%
DCF (EBITDA 5y) (56.45) - (67.28) (1,234.50) -123450.0%
DCF (EBITDA 10y) (93.88) - (116.84) (1,234.50) -123450.0%
Fair Value -171.29 - -171.29 -171.29 -237.06%
P/E (110.72) - 10.09 (65.53) -152.4%
EV/EBITDA (34.42) - (24.85) (37.21) -129.8%
EPV 36.70 - 48.32 42.51 -66.0%
DDM - Stable (89.80) - (501.67) (295.74) -336.6%
DDM - Multi 4.16 - 18.21 6.79 -94.6%

LGND Intrinsic Value - Key Valuation Metrics

Market Cap (mil) 2,410.86
Beta 0.95
Outstanding shares (mil) 19.29
Enterprise Value (mil) 2,362.90
Market risk premium 4.60%
Cost of Equity 7.29%
Cost of Debt 328.69%
WACC 7.29%